Marfloxin 20 mg Tablets for Dogs
Marfloxin 20 mg Tablets for Dogs
Authorised
- Marbofloxacin
Product identification
Medicine name:
Marfloxin 20 mg Tablets for Dogs
Active substance:
- Marbofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Marbofloxacin20.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- box containing 100 tablets (10 blister)
- box containing 10 tablets (1 blister)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
- TAD Pharma GmbH
- Krka-Farma d.o.o.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V443046
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0317/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
eu-PUAR-esv0317002-dcp-marfloxin-20-mg-tablets-for-dogs-en.pdf
English (PDF)
Download Published on: 21/12/2023
